Trial intelligence / Profile preview

Effect of N-Acetyl-L-Leucine in Treatment of Multiple Sulfatase Deficiency

IRCT20210413050958N5Phase 2Completed

Sponsor
Mashhad University of Medical Sciences
Start
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of levacetylleucine in multiple sulfatase deficiency (MSD), sponsored by Mashhad University of Medical Sciences. Started May 2022; status: completed.

02

Drugs

levacetylleucine
03

Conditions

multiple sulfatase deficiency (MSD)

Beyond the preview

Go deeper on IRCT20210413050958N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210413050958N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call